Replies to post #15344 on GTC Biotherapeutics (fka GTCB)

[croumagnon]

"Everyone just needs to put their anger and egotism"

This is not about anger or egotism, although sonme of that is present. But, whichever way you slice it, management has essentially taken the path that LFB is their angel and they are giving them the whole bonanza for that privilige. This deal is good for LFB and it is also possibly good for management as it safegards their job versus other alternatives, but I do not consider it good for shareholders as I think LFB will eventually takeover GTCB for a song if we proceed down that path. $0.6 may be too cheap for what we thought a litle while ago but it is a lot better than the less than $0.31 that we would get from LFB come next summer...

"Do all of us a favor Croug and move on..."

If you search my posts you will notice that I have already sold most of my position. As to moving on, sorry but I do not plan to do so as I am interested in seeing whetre this thing will take us even if my position now is less than 10% of what it used to be, especially since many of my friends and relatives bought in at my recommendation...

[n4807g]

Last time I checked the BOD's primary responsibility is protecting and enhancing the value of the company for the shareholders benefit. You're right; the entire future of this company does ride on the pending decision on ATryn. I don't see this situation as a "success", but rater a "failure". It's hard to imagine the fate of a company whittled down to a panel decision on one drug.

The BOD and exec's seem to have managed to maneuver the company into a very precarious position. I don't consider that particularly impressive?

Let us hope the FDA gives swift approval, for the sake of all the long term shareholders.

[DewDiligence]

>…go back over their history, they are, so I think we should be…<

I do not understand what you mean; however, because you mentioned history, I will post a table that summarizes the history of GTC from the standpoint of the company’s shareholders.

Please see the next post.